SCHEMBL7772052

SCHEMBL7772052

Cc1cc(Cc2ccccc2)c(NC(=O)NCc2ccccc2)c(=O)n1CC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.48
ALDH1A1 P00352 5/20 0.48
MAPK1 P28482 2/20 0.48
RCE1 Q9Y256 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.45
LMNA P02545 3/20 0.45
TACR1 P25103 1/20 0.43
KMT2A Q03164 3/20 0.42
HPGD P15428 3/20 0.42
MEN1 O00255 2/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 2/20 0.41
HTT P42858 1/20 0.41
F2 P00734 1/20 0.41
ADORA3 P0DMS8 1/20 0.40
FPR1 P21462 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7380302 0.81 NPC1 (0.48) KDM4EALDH1A1MAPK1RCE1SMN1; SMN2
SCHEMBL7773550 0.77 F2 (0.48) KDM4EALDH1A1MAPK1RCE1SMN1; SMN2
SCHEMBL8123909 0.77 CYP1A2 (0.45) KDM4EALDH1A1MAPK1RCE1SMN1; SMN2
SCHEMBL7377097 0.76 KDM4E (0.44) KDM4EALDH1A1MAPK1RCE1SMN1; SMN2
SCHEMBL7773547 0.75 SMN1; SMN2 (0.43) KDM4EALDH1A1MAPK1RCE1SMN1; SMN2
SCHEMBL7376547 0.74 METAP2 (0.44) KDM4EALDH1A1MAPK1RCE1KMT2A
SCHEMBL7767810 0.72 PTGDR2 (0.42) MAPK1LMNARAB9AMAPT
SCHEMBL8817030 0.69 LCK (0.65) KDM4EALDH1A1SMN1; SMN2LMNAKMT2A
SCHEMBL7371665 0.68 F2 (0.49) F2
SCHEMBL7376688 0.68 F2 (0.42) KDM4EALDH1A1MAPK1RCE1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6252082-B1 CARDIOVASCUALR DISORDERS SANOFI-SYNTHELABO (FR) 2001-06-26 US disclosed